Metformin and carbohydrate-modified diet: A novel obesity treatment protocol: Preliminary findings from a case series of nondiabetic women with midlife weight gain and hyperinsulinemia

Heart Disease

Volumn 3, Issue 5, 2001, Pages 285-292

  Mogul, H R ^a   Peterson, S J ^a   Weinstein, B I ^a   Zhang, S ^a   Southren, A L ^a  

^a Munger Pavillion   (United States)

Author keywords

Hyperinsulinemia; Insulin resistance; Menopause; Obesity; Weight gain

Indexed keywords

METFORMIN;

ADULT; ARTICLE; BODY MASS; CARBOHYDRATE DIET; CLINICAL ARTICLE; DIET RESTRICTION; DIET THERAPY; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; LOW CALORY DIET; OBESITY; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 0035205980     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00132580-200109000-00002     Document Type: Article

References (41)

1. Obesity
2. Current views on obesity
3. Pharmacotherapy for obesity: Do the benefits outweigh the risks?
4. Evaluation of drugs for treating obesity
5. One year comparative trial of metformin and glipizide in type 2 diabetes mellitus
6. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
7. The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution
8. Effects of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women
9. Metformin improves insulin, body fat distribution, and androgens in obese women with and without the polycystic ovary syndrome
10. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome
11. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation
12. Metformin in the treatment of HIV lipodystrophy syndrome: A randomized controlled trial
13. Effect of metformin on food intake in obese subjects
14. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes
15. Body weight and mortality among women
16. Weight-reducing effect of diguanides in obese non-diabetic women
17. Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome
18. Orlistat in the long-term treatment of obesity in primary care settings
19. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: A randomized controlled trial
20. Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients
21. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity
22. One-year treatment of obesity: A randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor
23. The effect of orlistat on body weight and coronary heart disease risk profile in obese patients: The Swedish Multimorbidity Study
24. Treatment with orlistat reduces cardiovascular risk in obese patients
25. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: Results from the DCCT
26. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49)
27. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children
28. Is fasting insulin concentration inversely associated with rate of weight gain? Contrasting findings from the CARDIA and ARIC study cohorts
29. An overview of metformin in the treatment of type 2 diabetes mellitus
30. Metformin improves glucose, lipid metabolism, and reduces blood pressure in hypertensive, obese women
31. Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: The BIGPRO1 study. Biguanides and the prevention of the risk of obesity
32. Treatment of pediatric obesity
33. Food provision vs structured meal plans in the behavioral treatment of obesity
34. Dietary fat intake does affect obesity!
35. Nutrition. The soft science of dietary fat
36. Dietary fat and obesity: An unconvincing relation
37. High protein vs high carbohydrate hypoenergetic diet for the treatment of obese hyperinsulinemic subjects
38. Randomized trial on protein vs carbohydrate in ad libitun fat reduced diet for the treatment of obesity
39. Dietary fiber, weight gain, and cardiovascular disease risk factors in young adults
40. A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women